Investigación Clínica

Arritmias y Muerte Súbita en la Enfermedad de Chagas

Iván Mendoza, Federico Moleiro, Juan Marques, Iván Mendoza Britto.
Section of Cardiology. Tropical Medicine Institute. Central University of Venezuela.

< anterior | Página 7 de 7 |

Referencias

1.- World Health Organization. Chagas’ disease. VI report of scientific working group on Chagas’ disease 1982
2.-Puigbo JJ, Nava JR, García M et al: A 4-year follow-up study of a rural community with endemic Chagas’ disease. Bull World Health Organ 1968; 39:341-8.
3.- Anselmi A, Moleiro F, Mendoza I: Cuadro clínico de la enfermedad de Chagas. Diagnóstico diferencial con la miocardiopatía dilatada o congestiva. Revista Latina Cardiologia 1982; 3:97-104
4.-Espinoza R, Carrasco H, Belandria F et al: Life expectancy analysis in patients with Chagas’ disease. International J Cardiol 1985; 8:45-56
5.- Oliveira JS: A natural human model of intrinsic heart nervous system denervation Chagas’ cardiopathy. Am Heart J 1985; 110:1092-8.
6.-Milei J. Mautner B, Storino R et al . Does Chagas´disease exist as an undiagnosed form of cardiomyopathie in the United States . Am Heart J 1992 ,123:1732-5
7.- Torres FW, Acquatella H, Condado J et al: Endothelium dependent coronary vasomotion is abnormal in patients with Chagas’ heart disease. J Am Coll Cardiol 1993; 21 Suppl A: 197 Abstract.
8.-Mengel JO, Rossi MA: Chronic chagasic myocarditis pathogenesis: dependence on autoinmune and microvascular factors. Am Heart J 1992; 124:1052-7.
9.-Mendoza I, Camardo J, Moleiro F et al: Sustained ventricular tachycardia in chronic chagasic myocarditis. Electrophysiologic and pharmacologic characteristics. Am J Cardiol 1986; 57:423-422
10.- Marques J, Matheus A. Dispersión del QT en enfermedad de Chagas . Revista Chilena de Cardiología 14(3):121;1995
11.- Takahashi N, Nakagawa M, Saikawa T et al. Regulation of QT indices mediated by autonomic nervous function in patients with type 2 diabetes. Int J Cardiol 2004;96(3):375-9
12.- Kearney MT, Fox KA, Lee AJ et al. Predicting sudden death in patients with mild to moderate chronic heart failure. Heart 2004;90(10):1137-43
13.- Aiba T, Shimizu W, Inagaki M et al. Excesive increase in QT interval and dispersion of repolarization predict recurrent ventricular tachyarrhythmia after amiodarone. Pacing Clin Electrophysiol 2004;27(7):901-9
14.- Engel G, Beckerman JG, Froelicher VF et al. Electrocardiographic arrhythmia risk testing. Curr Probl Cardiol 2004;29(7):365-432
15.- Marin-Neto JA, Simoes MV ,Sarabanda A. Chagas´ Heart Disease Arq Bras Cardiol 1999; 72(3): 264-80
16.- Hagar JM, Rahimtoola SH. Chagas´heart disease in the United States . N Eng J med 1991;325:763-8
17.-Mendoza I, Moleiro F, Marques J et al. Sudden Death in Chagas´disease G Ital cardiol 1998;28(1): 386-9
18.- Mendoza I, Moleiro F, Posse R et al. Validez de un protocolo de estudio para el tratamiento de arritmias ventriculares en la miocarditis crónica chagásica. Utilidad de la mexiletina . Rev Latina Cardiol 1982;3:505-11
19.- Brugada P, Brugada J . Right bundle branch block, persistent ST segment elevation and sudden death. A distinc clinical and electrocardiographic syndrome JACC 1992;20:1391-6
20.- Mendoza I , Giniger A, Kuschnir et al. Consenso do comité de Electrofisiología da USCAS sobre o tratamento das arritmias ventriculares na doenca de Chagas Arq Bras Cardiol
1994;62:41-3
21.- Medina V, Rodriguez L, Mendoza I, Castellanos A., Nonfatal ajmaline cardiotoxicity . Am J Card 1984;53:58-9
22.- Naccarella F. , Braccheti D. Arritmia ventriculari maligne ed arresto cardiacao in pazienti con blocco bi branca destra persistente soprelivellamiento del trato ST in V1-V3. Proabilmente un quadro di cardiomiopatíaaritmogena del ventricolo destro . G Ital cardiol 1993;23:1219-24
23.- Chiale PA, Prybyski J, Laino RA et al. Electrocardiographic changes evoked by ajmaline in chronic Chagas´disease with manifest myocarditis. Am J Card 1982;49(1):14-20
24..- I Mendoza, J Marques, F Moleiro, H Acquatella, F Misticchio, A Matheus, I Mendoza-Brito, A Octavio Un nuevo síndrome familiar inducido por interacción del trypanosome cruzy con los canales de sodio dependietes del gen SCN5A Avances Cardiológicos 26(1); S-35,2006
25.- I Mendoza, J Marques, I Palacios, D Corrado, I Mendoza-Britto, S Priori, L Pulpon, F Moleiro, F Misticchio. A new familial syndrome induced by the interaction of trypanosome cruzy with the cardiac sodium channel gene SCN5A JACC 2007; March 6; 56A
26.- Moleiro F, Mendoza I: 15 years prospective study in chronic chagasic cardiomyopathy. Circulation 1978; 58:113 Abstract
27.-Mendoza I, Moleiro F, Marques J: Morte subita na doenca de Chagas. Arq Bras Cardiol 1992; 59:3-4.
28.-Mendoza I, Moleiro F, Posse R et al: Validez de un protocolo de estudio para el tratamiento de arritmias ventriculares en la miocarditis crónica chagásica. Utilidad de la mexiletina. Rev Latina Cardiol 1982; 3:505-11.
29.-Lopes ER, Chapadeiro E, Almeida HO et al: Contribuicao ao estudo da anatomia patologica dos coracoes de chagasicos falecidos subitamente. Rev Soc Bras Med Trop 1975; 9:269-82
30.- I Mendoza, F Moleiro , J Marques, M Muñiz, A Matheus, A Rodriguez Variación Circadiana y circunstancias de la vida que preceden a la muerte súbita Avances Cardiológicos 14(4);17:1994
31.- I Mendoza, J Marques, F Moleiro, I Mendoza-Britto Comparison of sudden death circadian rhythm in chagasic versus non chagasic patients European Journal of Heart Failure Supplements 2007; Vol. 6(1), page 160
32.-Valero de Pesce EM, Favaloro M, Pesce RA et al: Automatic implantable cardioverter-defibrillator: 4 year experience. Rev Arg Cardiol 1991; 59:4-11.
33.-Doval HC., Nul DR, Grancelli HD et al. Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994;344:493-8
34.- Rassi A. Implantable Cardioverter-Defibrillators in Patients with Chagas Heart Disease: Misperceptions, Many Questions and the Urgent Need for a Randomized Clinical Trial. J Cardiovasc Electrophysiol, Vol. 18, pp. 1241-1243, December 2007
35.- de Paola AAV, Melo WDS, Tavora MZP , Martinez EE. Angiographic and electrophysiological substrates for ventricular tachycardia mapping through the coronary veins. Heart 1998;79:59-63
36.-Sosa E, Scanavacca M, dÁvila A et al. Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia . J Cardiovasc Electropysiol 1998;9:229-39